Senior Counsel Eric Pearson was quoted in an article in The Indiana Lawyer, “Cameras in court: 7th Circuit ushers in oral arguments on video,” about the Seventh Circuit Court of Appeals’ decision to allow videotaping of oral arguments.
Pearson said the court has the ability to allow attorneys to either call or videoconference if an unforeseen event keeps them from appearing in person. He told the story of one lawyer who argued his case over his cellphone from the side of the road after being involved in a traffic accident.
He also suggested that the presence of cameras would have little effect on oral arguments, saying a successful appellate appearance will still have to include having a good dialogue with the judges and answering all their questions.
Pearson said the court has the ability to allow attorneys to either call or videoconference if an unforeseen event keeps them from appearing in person. He told the story of one lawyer who argued his case over his cellphone from the side of the road after being involved in a traffic accident.
He also suggested that the presence of cameras would have little effect on oral arguments, saying a successful appellate appearance will still have to include having a good dialogue with the judges and answering all their questions.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”